Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This research study is designed to see if Capecitabine and Lenvatinib in combination with
external radiation therapy are effective in treating locally advanced rectal adenocarcinoma
in patients who have not yet had surgery, and what the best dosage is.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute